An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack
Migraine, Photophobia, Phonophobia
About this trial
This is an interventional treatment trial for Migraine focused on measuring Migraine, Photophobia, Phonophobia, Aura
Eligibility Criteria
Inclusion Criteria: Male and Female subjects 18-65 years of age Primary diagnosis of migraine attack with aura or migraine attack without aura Migraine history of averaging at least 1 migraine attack per month but averaging not more than 6 migraine attacks per month over the prior year Female subjects must use an effective form of birth control Listing of additional inclusion criteria are available through the Sponsor Exclusion Criteria: Excluding subjects with a history of other serious events causing secondary headaches Excluding subjects with a current medical condition that could interfere with the overall study intent or affect the absorption, distribution, metabolism, or excretion of the study medication Excluding subjects with a history or current medical condition that could confound the study results or use of a concomitant medication that could interfere with the study drug Listing of additional exclusion criteria are available through the Sponsor
Sites / Locations
- Associated Neurologists of Southern CT
- New England Center for Headache
- LCFP Inc.
- Palm Beach Neurological Center
- Diamond Headache Clinic
- International Research Center
- Michigan Head-Pain and Neurologic Institute
- Mercy Health Research
- New York Headache Center
- Headache Wellness Center
- DermResearch, Inc.
- J&S Studies, Inc.
- Houston Headache Clinic
- Road Runner Research, Ltd.
- The Innovative Clinical Research Center
- Advanced Healthcare, S.C.